| SpectraBase Spectrum ID |
4x5U8xk2bnB |
| Name |
N-Benzylpiperazine |
| CAS Registry Number |
2759-28-6 |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.11 (f) (3) |
| DEA Controlled Substance Name |
N-Benzylpiperazine |
| DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
| DEA Controlled Substances Code Number |
7493 |
| DEA Schedule |
Schedule I |
| DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers. |
| Exact Mass |
176.131348523 u |
| Formula |
C11H16N2 |
| InChI |
InChI=1S/C11H16N2/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13/h1-5,12H,6-10H2 |
| InChIKey |
IQXXEPZFOOTTBA-UHFFFAOYSA-N |
| Ionization Type |
Chemical Ionization (CI) |
| Molecular Weight |
176.263 g/mol |
| Nominal Mass |
176 u |
| Reagent Gas |
Methane |
| Retention Index |
1474 |
| SMILES |
C(N1CCNCC1)C1=CC=CC=C1 |
| SPLASH |
splash10-004i-1910000000-ed70233d22d4254e0e6b |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
BZP
1-Benzylpiperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_002530 |
